Skip to content

Comparing Active Versus Passive Aspiration in Therapeutic Thoracentesis: Efficacy, Procedure Time, and Patient Safety

Comparing Active Versus Passive Aspiration in Therapeutic Thoracentesis: Efficacy, Procedure Time, and Patient Safety

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07184736
Acronym
Thoracentesis
Enrollment
60
Registered
2025-09-22
Start date
2020-03-01
Completion date
2022-03-01
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pleural Effusion

Keywords

Pleural Effusion, Thoracentesis, Active Aspiration, Passive Aspiration, Procedural Complications, Gravity Drainage, Manual Aspiration

Brief summary

This single-blind randomized controlled trial (RCT) aims to compare the efficacy and safety of active manual aspiration versus passive gravity drainage during therapeutic thoracentesis for large symptomatic pleural effusions. A total of 60 eligible patients will be randomized into two equal groups. The active aspiration group will undergo fluid removal using manual syringe suction, while the passive aspiration group will undergo drainage via gravity. The primary outcomes of the study are the total procedure time and the volume of pleural fluid aspirated. Secondary outcomes include patient-reported pain (measured on a Numeric Rating Scale), patient-reported dyspnea (measured by the mMRC scale), the incidence of procedure-related cough, and the reason for procedure termination. The goal of this study is to determine which technique offers a better balance of efficiency and patient comfort.

Interventions

PROCEDUREActive Manual Syringe Aspiration

For the Active Manual Syringe Aspiration, the operator manually withdraws pleural fluid using a syringe attached to a 3-way stopcock and transfusion set. The fluid is then expelled into a collection bag.

PROCEDUREPassive Gravity Drainage

In Passive Gravity Drainage, after confirming proper needle placement with initial aspiration, the syringe is detached, and pleural fluid is allowed to drain passively by gravity through the transfusion set into a collection bag.

Sponsors

Sheikh Zayed Federal Postgraduate Medical Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients of either gender. * Aged above 18 years. * With symptomatic large pleural effusion (either exudative or transudative). * Requiring therapeutic pleurocentesis. * Modified Medical Research Council (mMRC) dyspnea scale grade 3-4.

Exclusion criteria

* Uncorrected bleeding diathesis. * Chest wall cellulitis at the intended site of puncture. * Uncooperative patients. * Loculated pleural effusion. * Traumatic hemothorax. * Empyema thoracis. * Hydropneumothorax. * Patients who refused to participate.

Design outcomes

Primary

MeasureTime frameDescription
Volume of Fluid AspiratedImmediately upon procedure completion (at the time of needle removal) and fluid extraction.The total volume of pleural fluid successfully removed during the procedure, measured in milliliters (ml).
Procedure Time for Therapeutic ThoracentesisImmediately upon procedure completion (at the time of needle removal) and fluid extraction.The total duration of the thoracentesis procedure, measured in minutes, from the initial needle insertion until the procedure was terminated. Termination occurred when no more fluid could be drained, the target volume was reached, or due to patient complications like cough or discomfort.

Secondary

MeasureTime frameDescription
Patient-Reported PainImmediately upon procedure completion (at the time of needle removal) and fluid extraction.The level of pain experienced by the patient during or immediately after the procedure, measured using the Numeric Rating Scale (NRS-11), an 11-point scale from 0 (no pain) to 10 (worst pain imaginable).
Patient-Reported DyspneaImmediately upon procedure completion (at the time of needle removal) and fluid extraction.Description: The level of shortness of breath (dyspnea) was measured using the modified Medical Research Council (mMRC) Dyspnea Scale. The mMRC scale is a 5-point grade-based scale (Range: 0 to 4) used to categorize the severity of a patient's disability due to breathlessness. A higher score indicates a worse outcome. Grade 0: No breathlessness except with strenuous exercise. Grade 1: Shortness of breath when hurrying on level ground or walking up a slight hill. Grade 2: Walks slower than people of the same age on level ground because of breathlessness, or has to stop for breath when walking at own pace on level ground. Grade 3: Stops for breath after walking about 100 meters or after a few minutes on level ground. Grade 4: Too breathless to leave the house, or breathless when dressing or undressing.
Incidence of CoughImmediately upon procedure completion (at the time of needle removal) and fluid extraction.The occurrence of cough during or at the end of the procedure, recorded as a binary outcome (yes/no).

Other

MeasureTime frameDescription
Reason for Procedure TerminationImmediately upon procedure completion (at the time of needle removal) and fluid extraction.The specific reason for stopping the procedure, categorized as: (1) target fluid volume (1-1.5L) achieved, or (2) terminated early due to complications (e.g., cough, chest discomfort) or spontaneous drainage cessation.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026